IVD Medical (HKG:1931) said it plans to list its shares in the U.S. and flagged an expected decrease in its H1 profit, according to a Hong Kong bourse filing Monday.
Shares of the medical equipment seller rose nearly 7% in morning trade Tuesday.
The company plans to list American depositary shares on the Nasdaq market in the U.S., though the proposal is at an early stage and requires that certain conditions be met, IVD Medical said.
Meanwhile, the company expects to report at least 33 million yuan in attributable profit for the six months ended June 30, compared to a profit of 125 million yuan in the comparable period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.